Fuman micro collapsed in the afternoon, and the stock price was close to the limit

Big Pharma CCHT’s Domination Unlikely to Fade Soon Despite Official Bulk Buying

The producer of long-acting growth hormone acupunctures, vaccines and other drugs, looks set to offset the effects of so-called “centralized procurement” on its product prices with more aggressive expansion into private hospitals. So far, its monopoly appears unshakable, but with more competitors upping the stakes, how long will it last?

Chip Design Company CMind Completes Pre-A+ Round Financing, 5G Chip Tape out in Q3

Domestic mobile communication chip market is huge, 5G IOT and telematics market is still in the blue ocean, and the market compound annual growth rate is at the forefront of the semiconductor industry.

20 Chinese Companies to Watch in Q1 2023 – Technology

Editor's note: We at EqualOcean tracked the major funding rounds or industry events that took place in China’s tech space in Q1 2023. The following is a list of deals that we have selected for you, based on a number of criteria, including the funding amount, the financial backers, the activity level and the segments in which the startups operate.

WaveFront Ventures: How Can Chinese Companies Win the Global Robotic Race

Here we present an exclusive interview with Ken Li, founder of WaveFront. Ken shared his insights into WaveFront's investment vision and strategies for Chinese companies going overseas.

CRM Software Provider EC Nets more than 100 Mn in Series D2

Business services are quietly changing. In the past, traditional CRM vendors have never been able to solve the problems of high costs of home-grown PaaS, long delivery cycles, and uncontrollable projects in the face of personalised enterprise needs. The new model of combining SaaS+PaaS will enable SaaS vendors to break out of the customisation trap.